Related Experiment Video
Updated: Aug 28, 2025

Self-Assembly of Microtubule Tactoids
Published on: June 23, 2022
Reconstitution of microtubule into GTP-responsive nanocapsules
Noriyuki Uchida1,2, Ai Kohata3, Kou Okuro4,5
1RIKEN Center for Emergent Matter Science, 2-1 Hirosawa, Wako, Saitama, 351-0198, Japan.
Abstract:
Nanocapsules that collapse in response to guanosine triphosphate (GTP) have the potential as drug carriers for efficiently curing diseases caused by cancer and RNA viruses because GTP is present at high levels in such diseased cells and tissues. However, known GTP-responsive carriers also respond to adenosine triphosphate (ATP), which is abundant in normal cells as well. Here, we report the elaborate reconstitution of microtubule into a nanocapsule that selectively responds to GTP. When the tubulin monomer from microtubule is incubated at 37 °C with a mixture of GTP (17 mol%) and nonhydrolysable GTP* (83 mol%), a tubulin nanosheet forms. Upon addition of photoreactive molecular glue to the resulting dispersion, the nanosheet is transformed into a nanocapsule. Cell death results when a doxorubicin-containing nanocapsule, after photochemically crosslinked for properly stabilizing its shell, is taken up into cancer cells that overexpress GTP.
Insights
Researchers developed novel nanocapsules that selectively collapse in response to guanosine triphosphate (GTP), offering targeted drug delivery for cancer and RNA virus infections. These GTP-responsive nanocapsules avoid triggering in normal cells, enhancing therapeutic safety.
Area of Science:
- Biotechnology
- Materials Science
- Nanomedicine
Background:
- Guanosine triphosphate (GTP)-responsive nanocapsules show promise for treating diseases like cancer and RNA viral infections.
- Existing GTP-responsive carriers also react to adenosine triphosphate (ATP), limiting their specificity as ATP is common in healthy cells.
Purpose of the Study:
- To engineer a nanocapsule that selectively responds to GTP, not ATP, for improved drug delivery.
- To utilize microtubule components for creating a novel, GTP-specific nanocarrier system.
Main Methods:
- Reconstituting tubulin monomers into nanosheets using a specific GTP/GTP* mixture at 37°C.
- Transforming nanosheets into nanocapsules via photoreactive molecular glue and photochemical crosslinking.
- Loading nanocapsules with doxorubicin for targeted cancer cell treatment.
Main Results:
- Successful formation of a tubulin nanosheet and its subsequent conversion into a stable nanocapsule.
- Demonstrated selective response of the nanocapsule to GTP.
- Induction of cancer cell death upon uptake of doxorubicin-loaded, crosslinked nanocapsules.
Conclusions:
- The novel microtubule-based nanocapsule selectively responds to GTP, enabling targeted drug delivery.
- This selective GTP response minimizes off-target effects in normal tissues, improving therapeutic potential.
- The developed nanocapsules offer a promising platform for treating GTP-overexpressing cancers and RNA viral infections.
Related Concept Videos
Microtubule Formation
Microtubule Instability
Microtubules
Destabilization of Microtubules
Drugs that Stabilize Microtubules
Microtubule Associated Proteins (MAPs)

